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Key features of an ideal RNA-based vaccine against coxsackievirus B3 (CVB3) are (i) limited genome replication/virus production (to
minimize vaccine-related pathology) and (ii) abundant virus protein synthesis (to maximize immunogenicity). These attributes may apply to
CVB3 RNAs lacking up to 250 nucleotides (nt) from their 5′ terminus; these RNAs do not give rise to infectious progeny, but they have been
reported to retain the entire CVB3 IRES (mapped to nt ∼432–639) and to produce large quantities of viral protein in transfected cells. Here, we
constructed five 5′ RNA deletion variants that, to our surprise, failed to protect against CVB3 challenge. We investigated the reasons for this
failure and conclude that (i) a 5′ terminal deletion as short as 32 nt abolishes CVB3 RNA replication in transfected cells; (ii) this deleted RNA, and
others with longer deletions, do not direct abundant protein synthesis in transfected cells, probably as a consequence of their replicative incapacity;
and (iii) the CVB3 IRES is substantially larger than previously thought, and its 5′ boundary lies between residues 76 and 125, very closely
approximating that of the poliovirus IRES.
© 2006 Elsevier Inc. All rights reserved.Keywords: Coxsackievirus; RNA vaccine; Picornavirus; IRESIntroduction
Coxsackievirus B3 (CVB3), a member of the genus
Enterovirus within the family Picornaviridae, is an established
human pathogen that causes heart disease (Woodruff, 1980;
Reyes and Lerner, 1985; Kishimoto and Hiraoka, 1994),
pancreatitis (Arnesjo et al., 1976; Imrie et al., 1977; Ramsingh,
1997; Mena et al., 2000) and meningoencephalitis (Modlin and
Rotbart, 1997; Daley et al., 1998). These infections are difficult
to treat and, to date, no approved vaccine is available. However,
efforts have been made to develop a vaccine against CVB3.
These include an inactivated vaccine (See and Tilles, 1994),
several live attenuated viruses (Gauntt et al., 1983; Fohlman et
al., 1993; Dan and Chantler, 2005) and DNAvaccines (Henke et
al., 1998). We have recently described an RNA vaccine, based
on a mutated full-length viral genome, that conferred some
degree of protection against disease (Hunziker et al., 2004). In
attempting to improve the efficacy of the RNA vaccine⁎ Corresponding author. Fax: +1 858 784 7380.
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doi:10.1016/j.virol.2006.09.041approach, we wished to generate a full-length genomic variant
that would retain the capacity to direct the synthesis of abundant
viral protein (thereby maintaining immunogenicity) but that
would be unable to replicate (thus enhancing its safety). To
design such a vaccine, we needed to know the boundaries of the
various genomic elements that controlled replication and
translation.
The CVB3 capsid is non-enveloped and contains a single-
stranded positive-sense RNA genome of ∼7400 nucleotides
(nt) in length (GenBank U57056: ref Knowlton et al., 1996).
The RNA molecule comprises a 5′ untranslated region (5′UTR)
of 742 nt, followed by a single open reading frame of 6555 nt
that encodes the ∼220-kDa viral polyprotein, which is co- or
post-translationally cleaved by virus-encoded proteases to
generate the mature protein products. Translational initiation
in eukaryotic cells usually requires that a pre-initiation complex
attaches to the m7GpppN cap at the 5′ end of an mRNA and
moves along the molecule, in a process termed scanning, until it
encounters the first potential translational initiation codon.
Picornaviruses represent an exception to the general rules
concerning ribosomal attachment. The mRNAs of these viruses
are uncapped, and seminal studies revealed a structure within
Fig. 1. The five deletions used to evaluate functional elements in the CVB3 5′
UTR, and their impact on predicted RNA folding motifs. Panel A: The
sequences involved in each of the 5 deletions in the CVB3 5′UTR are shown in
color, and the numbers of bases missing (Δ) in each of the IH2–IH6 series are
shown in parentheses. The grey box indicates the core of the CVB3 IRES, as
indicated by published studies (Liu et al., 1999), and the arrow demonstrates the
approximate location of the poliovirus type 2 IRES (Nicholson et al., 1991).
Panel B presents a cartoon of the predicted folding of the first 481 nt of the
CVB3 genome, according to the Zuker algorithm (see text). The numerals
indicate the number of nt from the 5′ terminus of the genome, the regions
affected by each deletion are color coded to correspond with panel A, and IRES
stem-loops I–IV are indicated.
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internal ribosomal entry site (IRES; Jang et al., 1988; Pelletier
and Sonenberg, 1988; Pelletier et al., 1988a). Most picornaviral
IRES elements belong to one of two groups, which differ in
sequence, secondary structure, and the location of the transla-
tional initiation codon. Enteroviruses (e.g., polioviruses and
coxsackieviruses) and rhinoviruses contain a type I IRES, and
the initiation codon is usually ∼50–150 nucleotides (nt)
downstream from the 3′ end of the ribosome binding site. The
boundaries of the IRES, and the importance of specific
sequences within the element, have been mapped for poliovirus;
the results indicate that the motif encompasses nt ∼140–631
(Meerovitch et al., 1991; Nicholson et al., 1991). However,
analyses of the CVB3 5′UTR suggested (i) that the core IRES of
this virus was located between nt 432–639, and thus was
∼200 nt shorter than that of poliovirus and (ii) that, perhaps as a
result of this apparently foreshortened IRES, the first 250 nt of
the CVB3 5′UTR could be deleted with only a modest (∼50%)
reduction in viral protein synthesis in RNA-transfected cells
(although virus production was abrogated) (Liu et al., 1999).
The phenotype of abundant protein synthesis in the absence of
infectious virus production appeared ideal for a putative RNA
vaccine and led us to prepare, from the full-length CVB3
genome, five variant RNAs containing deletions in the 5′UTR.
However, none of these variants conferred protection against
disease in mice. This observation caused us to re-evaluate the
sequences in the CVB3 5′UTR that regulate viral replication
and protein synthesis.
Results
Generation of a family of 5′ deletion variants, based on a
full-length infectious CVB3 genome
Based on published findings, CVB3 mutants bearing
deletions outside the IRES (for example, deletion of residues
1–63 or of 1–249) should have minimal effect on translation in
transfected cells, while viral infectivity should be completely
abolished (Liu et al., 1999). Because these qualities were well-
suited to an RNA vaccine, we generated a series of deletions,
varying in size between 32 nt and 209 nt, in the 5′UTR of an
infectious full-length CVB3 genome. An infectious clone of the
cardiopathogenic Woodruff strain of CVB3, pH3, was used as a
parental plasmid for the construction of the deletion mutants by
site-specific PCR-based mutagenesis. The 5′UTRs of pH3 and
the resulting five variants, termed IH2–IH6, are shown
diagrammatically in Fig. 1A. The five regions targeted for
deletion are color coded, and the proposed “core” of the CVB3
IRES (nt 432–639) is shown as a grey box; all five deletions
terminate >200 nt upstream of this area. RNA folding
algorithms have been applied to the 5′UTR of enteroviruses
and have revealed extensive secondary structure, some of which
has been experimentally confirmed. For the CVB3 5′UTR, it
has been suggested that there may be 11 stem-loops (termed
A-K), two of which (A and B) were predicted within the first
∼100 bases; and deletion analyses indicated that sequences up
to and including much of stem-loop E (which ends at residue481) precede the 5′ boundary of the IRES (Liu et al., 1999). For
this reason, we applied the RNA folding predictive algorithm
(the GeneQuest component of Lasergene software, DNAStar,
Madison WI) to this region of the CVB3 5′UTR (Fig. 1B), and
the predicted structure – which differs from the above, but is
similar to that of other enteroviruses such as poliovirus – is
shown, with the stem-loops labeled I–IV. The locations of the 5
deletions relative to the proposed RNA folds are shown; none of
them impinge on the complex structure previously termed stem-
loop E, only the latter part of which lies within the proposed core
of the CVB3 IRES.
All five variants fail to produce infectious virus, but none
induces protective immunity
To maximize RNA vaccine safety, it is important that the
production of infectious virus be minimized. Each of the six
RNA molecules shown in Fig. 1A was transfected into
susceptible HeLa cells, and 48 h later the cells and supernatants
were assayed for the presence of infectious virus; this was
detected only following transfection of the wild-type (pH3)
RNA (Fig. 2A). To better evaluate the attenuation of these RNA
Fig. 2. Deletions in the 5′UTR prevent production of infectious virus, but also abrogate protective efficacy. Panel A: HeLa cells were transfected with 3 μg of the
indicated RNAs and, 48 h later, supernatants were harvested. The titers (if any) of infectious virus are shown. Panel B: C57BL/6 mice (4/group) were injected with
15 μg of the indicated RNAs, and 5 days later the mice were sacrificed and virus titers were determined in hearts, spleens and pancreata. The heart titers are shown (pfu/
gram) and are representative of the titers in the other organs. Panel C: Representative histological samples of the pancreata from mice infected with pH3 RNA (left) or
IH2 RNA (right) are shown (stained with Masson's trichrome). Marked inflammatory infiltrates and acinar cell destruction are evident in the former sample, while the
latter tissue appears histologically normal. Panel D: Mice (4/group) were immunized, and boosted once, with the indicated vaccines (see text for details) and, 3 weeks
after the boost, were challenged with 8000 pfu of wild type CVB3 (H3). Two days post-infection, feces were collected, and the virus titers therein are shown
(pfu/gram).
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tibialis anterior muscle of mice (4 mice per RNA). Five days
later, virus titers in heart, spleen and pancreas were measured.
Virus was detected only in the tissues of mice that had received
pH3 RNA. The titers in heart are shown in Fig. 2B and are
representative of titers in all three organs. Furthermore, the
direct in vivo injection of picornavirus RNA can result in
pathology, if the RNAwas derived from a pathogenic virus. As
shown in Fig. 2C (left panel), dramatic pancreatitis was present
5 days after injection of pH3 RNA, but no pathology was
observed following injection of any of the five variant RNAs
(IH2 shown as example, right panel). All of these results were
consistent with published data and were generally desirable for
candidate vaccines. Next, we evaluated the protective efficacy
of the RNAs. 15 μg of each of the five variant RNAs was
inoculated into C57BL/6 mice (4 per group). As a negative
control, four mice were inoculated with 15 μg of an RNA
encoding β-galactosidase. pH3 RNA was not used in this
vaccination experiment, as it encodes wild-type virus, and
causes disease (Fig. 2C); therefore, as a positive control
vaccine, an attenuated recombinant virus encoding enhanced
green fluorescent protein was used; we have previously shown
that this virus is non-pathogenic in vivo but induces strong
protective immunity (Hunziker et al., 2004). Three weeks later,
all mice received booster vaccinations identical to the originals,and three weeks thereafter, all mice were challenged with
8000 pfu of wild-type CVB3. Fecal titers were measured two
days later (Fig. 2D). Virus was undetectable in the mice that had
been immunized with the attenuated rCVB-eGFP. In contrast,
very high viral titers (108–109 pfu/gram) were present in
recipients of each of the five candidate RNA vaccines and
were indistinguishable from those observed in recipients of
β-galactosidase RNA. This failure of protection was unexpected
because CVB3 deletion variants lacking nt 1–63, or 1–249, have
been reported to produce substantial quantities of viral protein
(∼50% of wild-type) following RNA transfection (Liu et al.,
1999). Consequently, we set out to identify the reason(s) for
vaccine failure.
All five deletions in the 5′UTR dramatically reduce viral
protein production in transfected cells
The most obvious reason for the lack of immunogenicity was
that insufficient viral protein was synthesized by cells that had
taken up the deleted RNAs. To address this possibility, the five
variant RNAs, or pH3 RNA, were transfected into HeLa cells,
and viral and host protein production was evaluated. Data for
cells transfected with the IH2 and IH3 constructs are shown in
Fig. 3A; the results for the IH4–IH6 constructs were very
similar. Virus proteins were readily detected in cells that had
Fig. 3. The effects of deletions in the 5′UTR on viral protein synthesis, and on RNA replication, in transfected cells. Panel A: HeLa cells were transfected with each of
the indicated RNAs, or were left unmanipulated (Un). Newly synthesized proteins were radiolabeled using S35 methionine (see Materials and methods) and, following
cell disruption, were separated on a polyacrylamide gel, which was subjected to autoradiography. Virus protein sizes are indicated to the left and are highlighted by dots
in the pH3-transfected extract. Panel B: HeLa cells were transfected with pH3 or IH2 RNAs, or were mock-transfected, and RNAwas extracted at the indicated 5 time
points. The amounts of positive-sense (left panel) and negative-sense (right panel) RNAs present at each time point was determined by slot blot. The density of each
signal was measured using ImageJ, and the results (arbitrary units) are shown in the lower graphs.
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dots) but were undetectable in cells transfected with any of the
RNA deletion mutants. Host cell proteins were present, and
quite abundant, in all extracts from RNA-transfected cell
populations; this is consistent with the fact that only a minority
of cells in each preparation will have been successfully
transfected. This result, although different from published
data, is consistent with the observed vaccine failure. The
absence of detectable viral proteins could be explained in
several ways, including (i) a difference in template abundance in
transfected cells; (ii) reduced efficiency of translational
initiation (if, for example, a deletion interfered with IRES
function); or (c) a combination of the above.
Following transfection, the abundance of wt RNA increases,
while that of the variant RNAs rapidly declines
Next, we estimated the abundance of potential translation
template in transfected cells. For each of the six constructs (wt
and 5 variants), 3 μg of RNA was transfected into HeLa cells,
and at 0, 3, 6, 12 and 24 h after transfection, RNA was
harvested, immobilized on a slot-blot apparatus and incubated
with radio-labeled strand-specific CVB3 RNA probes. Repre-
sentative autoradiographs for pH3 and IH2 RNAs are shown in
Fig. 3B. Band intensities were measured using ImageJ software,
allowing quantitation of the changes in genomic and anti-
genomic RNA contents over time. At t=0, the band intensities
of the genomic RNAs were comparable in the pH3 and IH2
samples, confirming that equal amounts of input RNA were
applied. The positive-sense RNA signal in pH3 RNA-
transfected cells dropped marginally in the first 3 h, thenincreased at first gradually (6 and 12 h), then dramatically
(24 h). In contrast, the positive-sense RNA signal in cells
transfected with IH2 RNA decreased constantly. These data
suggest that the pH3 RNA was successfully replicated within
the transfected cells, while the IH2 RNA was not. This
hypothesis is consistent with the appearance of anti-genomic
(negative sense) RNA in cells transfected with pH3 RNA, but
not in cells transfected with IH2 RNA (Fig. 3B, right-hand
panels). We conclude that the deletion of as few as 32 nt of the
5′ terminus of CVB3 prevents genome amplification. The
results for the remaining four deletion mutants (not shown) were
indistinguishable from IH2. Therefore, all five deletions limit
the abundance of positive-sense RNA (potential translational
template) in transfected cells; this provides one explanation for
the absence of detectable virus proteins in cells transfected with
RNAs IH2–IH6 (Fig. 3A).
In vitro translation data suggest that the CVB3 IRES is larger
than previously proposed and is similar in size to its poliovirus
counterpart
The absence of RNA amplification provided a convincing
explanation for vaccine failure, but we wished to determine
whether or not the deletions also had an effect on the ability of
the individual RNA molecules to act as templates for
translation. The five variant RNAs, and pH3 RNA as a positive
control, were transcribed in vitro using T7 RNA polymerase and
were added to an in vitro translation reaction, as described in
Materials and methods. After a 4-h incubation, the labeled
proteins were analyzed by gel electrophoresis and autoradio-
graphy, and the resulting data are shown in Fig. 4. As expected,
Fig. 4. In vitro translation indicates that the CVB3 IRES is larger than previously
determined and is similar in extent to that of poliovirus. Each of the six indicated
uncapped RNAs was incubated for 4 h in an in vitro translation reaction, carried
out in the presence of 35S-methionine, and aliquots of reaction mixtures were
analyzed by polyacrylamide gel electrophoresis followed by autoradiography.
The extent of each of the 5 deletions is shown above each lane (Δ), and the
position of each virus protein is shown on the left side.
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template. In addition, the IH2 and IH3 RNAs were translated at
high efficiency; all major coxsackievirus bands including P1,
P3, 3CD, 3D, 2BC, VP0, 2C, VP1, VP3, 3C, 2A and 3AB are
present in all three lanes representing pH3, IH2 and IH3. From
this analysis, we cannot exclude minor effects of the IH2 and
IH3 deletions because, when compared with the pH3 sample,
the intensities of the VP0 and VP3 bands appear to slightly
decline across these three samples. At present, we cannot
explain this observation; one obvious possibility is a change in
post-translational processing similar to a previous report from
our laboratory (Harkins et al., 2005), but the absence of the
precursor protein, VP0–VP3, argues against this. Nevertheless,
these data show that the first 75 residues of the CVB3 5′UTRcan be removed without dramatically interfering with in vitro
translation; this conflicts with previous in vitro translation data,
which indicated that deletion of the first 63 nucleotides had a
profound negative effect (Yang et al., 1997). In contrast to these
possible minor effects, the deletion of a further 50 bases (IH4)
causes a profound change in virus protein translation. This
deletion completely abrogates protein synthesis from the RNA
template, an outcome that is observed also in the remaining two
deletion variants IH5 and IH6. Our approach, like the vast
majority of published studies, does not directly measure
ribosome entry/assembly, and instead relies on the end result,
translation; but the resulting data strongly suggest that the 5′
boundary of the CVB3 IRES extends to between residues 76–
125 of the viral 5′UTR, some 200–300 nt closer to the 5′
terminus than previously thought, and similar to the location
identified in poliovirus.
Discussion
The 5′UTR of picornaviruses regulates not only translation,
but also replication, and contributes to the control of viral
pathogenesis and tissue tropism (Semler, 2004). A previous
report indicated that a CVB3 RNA bearing a deletion of nt 1–
249 in the 5′UTR, when transfected into HeLa cells, caused
very little cytopathic effect (CPE) but still produced abundant
viral protein (∼50% of the wt level; Liu et al., 1999), which
appeared to be attributes of an ideal candidate RNAvaccine. For
this reason, we prepared a number of similar deletion variant
RNAs, lacking 32 to 209 nt from the CVB3 5′UTR (Fig. 1).
None of the RNA constructs gave rise to infectious virus, as
expected (Figs. 2A–C), and consistent with the earlier report.
Surprisingly, however, nor did they confer any degree of
protective immunity (Fig. 2D). Our subsequent analyses
provided a plausible explanation for their poor immunogenicity;
none of the deletion RNAvariants gave rise to a detectable level
of viral protein within transfected cells (Fig. 3A). This
observation, in turn, could be attributed to two independent
phenomena: all five RNAs were replication defective, resulting
in lower numbers of potential translation templates in
transfected cells (Fig. 3B); and the IH4–IH6 RNAs also
showed defects in translation, consistent with the upstream
boundary of the CVB3 IRES lying closer to the 5′ end than
previously thought (Fig. 4).
Analyses of the viral RNA content of transfected cells (Fig.
3B) showed clearly that, in contrast to wt RNA, the quantity of
positive-strand IH2–IH6 RNAs decreased over time, and
antigenomic material was never detected. These findings
provide a likely explanation for the failure of a 1–63 deletion
mutant to cause a CPE in transfected cells (Liu et al., 1999). We
considered the possibility that the deleterious effects of the
IH2–IH6 deletions resulted from destabilization and rapid
degradation of these RNAs, rather than a direct inhibition of
their replicative capacity. We cannot completely exclude RNA
destabilization as a possible mechanism, but we believe it to be
unlikely because the input IH2 RNA remained readily
detectable (albeit at decreasing amounts) over a period of
24 h after transfection of tissue culture cells (Fig. 3B), and the
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IH6 RNAs (data not shown). Therefore, we conclude that the
sequences at the immediate 5′ terminus of the CVB3 genome
are required for RNA replication. To our knowledge, the
importance of these sequences to CVB replication has not been
previously demonstrated. However, it can be argued that these
findings are not surprising. The secondary RNA structure
predicted in Fig. 1B differs somewhat from a folding pattern
previously proposed (Yang et al., 1997; Liu et al., 1999), mainly
because the structure shown in Fig. 1B contains a “cloverleaf”
within the first∼100 nucleotides, rather than two separate stem-
loops. At least four different approaches have indicated that this
cloverleaf is likely to be present in the 5′UTR of CVB3. (i) A
similar structure has been reported in several enterovirus and
rhinovirus 5′UTRs and forms a ribonucleoprotein complex with
the viral 3C polypeptide (Andino et al., 1990; Leong et al.,
1993) or the 3CD precursor protein, as well as the host poly r(C)
binding protein (PCBP) (Andino et al., 1993). (ii) Circular
dichroism data are consistent with a cloverleaf's being present
in CVB3, and gel-shift assays (Zell et al., 2002) together with
NMR spectroscopy (Ohlenschlager et al., 2004) indicate that the
CVB3 3C protein binds to the fourth stem-loop in the proposed
structure. (iii) The formation of a nucleoprotein complex at the
cloverleaf is an absolute requirement for polioviral RNA
replication, suggesting that it may be important for CVB. (iv)
A chimeric virus, in which poliovirus nucleotides 1–627 were
replaced with the equivalent CVB sequence, showed biosyn-
thetic properties similar to those of the parental poliovirus
(Johnson and Semler, 1988), indicating that the poliovirus-
encoded proteins interacted with a CVB-derived cloverleaf.
These published data, although very strongly suggestive, do not
definitively demonstrate a requirement for these 5′-terminal
sequences in CVB replication; the data herein provide
conclusive evidence that this is the case. Furthermore, our
data take on additional significance in light of a recent,
intriguing report that CVB infection in vivo gives rise to 5′UTR
deletion mutants that are very similar to those constructed
herein; these naturally occurring mutants cause no CPE and
appear to replicate at low levels, and purified viral capsids
contain a high proportion of negative-strand RNA (Kim et al.,
2005). We found no evidence that our deletion mutants gave rise
to such viral variants, and our in vivo histological analyses (Fig.
2C) suggested that the IH2–IH6 RNAs were non-pathogenic;
but the approaches taken in our study may not have been
sufficiently sensitive to have allowed the detection of these
species.
Next, we evaluated the capacity of each of the six RNA
templates to direct viral protein synthesis in a cell-free system,
and found that IH2 and IH3 were relatively efficient, while
IH4–IH6 were completely inactive (Fig. 4). These data place
the 5′ end of the CVB3 IRES somewhere between nt 76 and
125 from the genome 5′ terminus. The fact that our
conclusions regarding the CVB3 5′UTR and IRES differ
from those already published is, perhaps, less surprising than it
might at first appear. An IRES often is presented as being a
distinct block of contiguous sequence, with well-defined
boundaries, but some sequence changes inside the IRES arewell tolerated, suggesting that the IRES itself is, to a greater or
lesser extent, an assembly of discontinuous parts. Even for the
prototypical IRES, in poliovirus, there remains some debate;
this motif has been subjected to careful analyses by a number
of laboratories and, although a consensus has emerged, fine
details differ (Trono et al., 1988; Pelletier et al., 1988b;
Nicholson et al., 1991; Haller et al., 1993). Contributing to the
variability, many methods have been employed in mapping the
functions of picornaviral 5′UTRs. Some are in vivo, others in
tissue culture and others still in cell-free systems. Some IRES
mapping studies have used sequence insertions and deletions
or linker scanning (Haller and Semler, 1992), others have used
hybrid arrest of translation. Furthermore, IRES mapping often
relies on somewhat indirect criteria to indicate ribosome
binding/assembly. Some studies are based on the detection of
viral proteins; others have employed the presence of absence
of CPE as an indicator of IRES function (Liu et al., 1999). In
this study, we have used cell-free protein synthesis as the
indicator of ribosome binding. Taken together, our data
suggest strongly that the CVB3 IRES may be considerably
larger than previously conceived, with its 5′ boundary lying at
a location that is directly comparable with the equivalent
poliovirus boundary. In summary, we conclude that a deletion
of the first 32 or 75 nt of the CVB3 genome (IH2 and IH3)
prevents RNA replication but has little effect on the efficiency
or fidelity of translation; and that deletion of an additional
50 nt (IH4) or more (IH5, 6) results in RNA molecules that
are defective in both replication and translation. For these
reasons, and because of the recent report that CVB bearing 5′
deletions may be able to persist in vivo (Kim et al., 2005),
such viral RNAs should not be considered as viable candidate
vaccines.
Materials and methods
Mice and tissue culture cells
Male C57BL/6 mice (H-2b MHC haplotype) were obtained
from The Scripps Research Institute (TSRI) breeding facility.
All animal experiments were approved by TSRI Animal Care
and Use Committee. HeLa cells were used for virus titrations
and RNA transfections and were maintained in Dulbecco's
modified Eagle medium (DMEM; GIBCO BRL, Invitrogen,
Carlsbad, CA) supplemented with 10% fetal bovine serum
(FBS), 2 mM L-glutamine, 100 U/ml penicillin and 100 μg/ml
streptomycin (complete DMEM).
Plasmids
The coxsackievirus B3 strain used is a plaque-purified
isolate (designated H3, van Houten et al., 1991) of the
cardiopathogenic Woodruff strain of CVB3. The plasmid
pH3, encoding a full-length infectious clone of this virus
(Knowlton et al., 1996), was generously provided by Dr. Kirk
U. Knowlton (University of California, San Diego) and was
used as the parental plasmid for the construction of the various
5′UTR deletion variants pH3IH2–IH6.
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The DNA templates (pH3, pH3IH2–IH6) were linearized
with the restriction enzyme ClaI (New England Bio Labs,
Beverly, MA), phenol-chloroform extracted, ethanol precipi-
tated, washed with 70% ethanol and resuspended in sterile
distilled water. One microgram of each DNA was used as a
template for transcription based on the MEGAscript kit
(uncapped RNA; Ambion, Austin, TX) according to the
manufacturer's directions, then the template DNAwas removed
by the addition of 1 μl of DNase, followed by incubation at
37 °C for 15 min. RNAwas recovered by ethanol precipitation.
In vivo RNA inoculation
RNA was suspended in sterile PBS at a concentration of
300 μg/ml, and 50 μl (15 μg) was injected into the tibialis
anterior muscle of mice. For the studies of RNA infectivity,
samples were harvested at the indicated times post-injection.
Organ preparation for titration and histology
The hearts, spleens and pancreata were removed from the
mice immediately after euthanasia. Each organ was divided into
two approximately equal portions, one of which was placed into
a cryotube and fast-frozen in dry ice for later virus titration. The
other portion of each organ was fixed in 10% normal-buffered
formalin and processed for histological analyses. Five-micron
paraffin sections were prepared and stained with Masson's
trichrome.
Plaque assays
HeLa cells were plated in six-well plates (5–7.5×105 cells/
well) and incubated at 37 °C with 5% CO2 for ∼24 h, at which
time they reached ∼70–90% confluency. The weight of each
frozen organ sample was determined, then the tissue was
homogenized in 1 ml of DMEM, and 10-fold serial dilutions
were prepared in DMEM. Media were aspirated from the 6-well
plates, and 400 μl of each serial dilution was added to individual
wells. Plates were incubated at 37 °C, with gentle rocking every
15 min. After 1 h, cells were overlaid with 4 ml of 1× DMEM in
0.6% agar (1:1 mixture of 2× DMEM at 37 °C and 1.2% agar at
55 °C). At ∼42 h post-infection, cells were fixed in methanol:
acetic acid (3:1 v/v), and agarose plugs were removed. The
monolayers were stained with 0.5% crystal violet in 20%
ethanol, rinsed in tap water, and plaques were counted. The titer
(pfu/g of organ) was calculated based on the weight of each
tissue sample.
Transfection of HeLa cells
To determine the infectious status of the RNA molecules and
to evaluate viral protein production in tissue culture, HeLa cells
(at about 70–80% confluency in a 6-well plate) were transfected
with 3 μg of the indicated uncapped RNA using Lipofectin and
OPTI-MEM (both GIBCO BRL, Invitrogen) according to themanufacturer's directions; in our hands, 25–50% of HeLa cells
express the desired gene products after transfection of nucleic
acids. After 3 h, the transfection mixture was aspirated and
replaced by complete media; this time point defined the
beginning of the post-transfection period.
Evaluation of virus protein synthesis in transfected cells
HeLa cells were transfected with uncapped RNA molecules
as described above and, 16 h later, were washed with saline and
starved for 30 min in methionine- and cysteine-free DMEM
containing 10% FCS at 37 °C. 200 μl of 35S-labeled amino
acids (MP Biomedicals, Irvine, CA) was added (0.3 mCi/ml
final activity), and a 1-h incubation at 37 °C followed. Cells
were resuspended in 30 μl of 1× SDS buffer, frozen, then boiled
for 5 min and applied to a 12.5% polyacrylamide gel, as
described in the text. The gel was dehydrated with 3 washes
using DMSO for 45 min each, and finally impregnated with
20% PPO in DMSO for 1 h. Another wash in running water
followed for 1 h, before the gel was dried on a gel-dryer at 65 °C
overnight and finally exposed to a photographic film.
Evaluation of RNA replication by slot-blot
HeLa cells were transfected with RNA as described above
and were harvested at 0, 3, 6, 12 and 24 h post-transfection.
RNA was extracted using TRIzol LS Reagent (Invitrogen)
according to the manufacturer's directions. All samples were
dissolved in an aqueous solution containing 50% formamide
(J.T. Baker Inc., Phillipsburg, NJ), 7% formaldehyde (Fisher
Scientific, New Jersey, NJ) and 1× SSC and incubated at 68 °C
for 15 min. Then, two volumes of 20× SSC (Ambion) were
added, and each RNA sample was loaded onto a nitrocellulose
sheet in the slot-blot manifold. After washing twice with 10×
SSC, the nitrocellulose was removed, air-dried, baked in a
vacuum oven at 80 °C for 2 h and finally crosslinked in a
Stratalinker at 200 J for 1 min. The nitrocellulose was pre-
hybridized at 68 °C for 2 h in 50% formamide, 6× SSC, 5×
Denhardt's reagent, 0.5% SDS (Ambion) and 100 μg/ml boiled,
denatured salmon sperm DNA. Radiolabeled probes, specific
for either the genome or antigenome and produced based on the
MAXIscript kit (Ambion), were added at 1×107 cpm/ml, and
the blots were incubated at 68 °C for approximately 16 h, after
which the nitrocellulose was washed three times: at RT using 1×
SSC, 0.1% SDS; at 68 °C in 0.2× SSC, 0.1% SDS; and finally
in 0.1× SSC, 0.1% SDS. The blot was exposed to a Kodak film
at −70 °C with an intensifying screen for ∼1–2 h. The
intensities of the bands on the resulting autoradiograph were
quantified using the public domain software ImageJ (available
at the NIH web site http://rsb.info.nih.gov/ij/).
In vitro translation
In vitro translation reactions were carried out as described
(Cornell et al., 2004). Uncapped RNA was produced using the
MEGAscript kit (Ambion). DNase-treated transcripts were
quenched with the addition of 375 μl of sodium dodecyl sulfate
127I.P. Hunziker et al. / Virology 360 (2007) 120–128(SDS) stop buffer (0.5% SDS, 100 mM NaCl, 10 mM Tris–HCl
[pH 7.5], 1 mM EDTA) and 100 μg of predigested proteinase K.
The resulting mixture was incubated at 37 °C for an additional
30 min, phenol-chloroform extracted and ethanol precipitated.
RNA pellets were washed with 70% ethanol, dried and
resuspended in diethyl pyrocarbonate-treated water. All tran-
scripts were quantified on an ethidium bromide-stained agarose
gel by using RNA of the same length and known quantity as a
standard. For the translation, 65% of S10 extract from
suspension HeLa cells, 1× “All four” buffer [10× buffer:
10 mMATP, 2.5 mMGTP, 2.5 mMUTP, 2.5 mM CTP, 600 mM
potassium acetate, 300 mM creatine phosphate, 4 mg of creatine
kinase per ml, 155 mM HEPES–KOH (pH 7.4)], 400 ng RNA
and 2 μl of 35S-methionine (Amersham Biosciences, Piscat-
away, NJ) were mixed and used in 20 μl reactions. The HeLa
S10 extract was generously provided by Prof. Bert L. Semler,
University of California, Irvine. The translation was performed
at 30 °C for 4 h, after which 2× lysis buffer was added, and the
reactions were heated to 90 °C for 5 min. Ten microliters of the
reactions was loaded and run on a 12.5% polyacrylamide gel.
The gel was dehydrated with three washes using DMSO for
45 min each and finally impregnated with 20% PPO in DMSO
for 1 h. Another wash in running water followed for 1 h, before
the gel was dried on a gel-dryer at 65 °C overnight and finally
exposed to a photographic film.
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